Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,585 | -26,955 | -12,323 | -47,590 | -39,799 |
| Depreciation Amortization | 3,650 | 2,384 | 1,161 | 5,992 | 4,856 |
| Income taxes - deferred | -133 | -144 | -131 | -5,163 | 31 |
| Accounts receivable | 1,163 | -314 | 1,539 | -1,856 | -834 |
| Accounts payable and accrued liabilities | -5,928 | -2,091 | -5,501 | 9,901 | 5,838 |
| Other Working Capital | -52,916 | -31,147 | -11,346 | -50,412 | -39,938 |
| Other Operating Activity | 26,796 | 18,352 | 11,000 | 16,983 | 14,570 |
| Operating Cash Flow | $-63,953 | $-39,915 | $-15,601 | $-72,145 | $-55,276 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,147 | -31,898 | -6,365 | 23,231 | -33,653 |
| PPE Investments | -3,594 | -2,527 | -1,097 | -4,949 | -3,684 |
| Purchase Of Investment | N/A | N/A | N/A | -10,000 | -10,000 |
| Other Investing Activity | 0 | 0 | 0 | 6,151 | 6,151 |
| Investing Cash Flow | $-29,741 | $-34,425 | $-7,462 | $14,433 | $-41,186 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,136 | 3,083 | 542 | 3,509 | 2,874 |
| Financing Cash Flow | $3,136 | $3,083 | $542 | $3,509 | $2,874 |
| Exchange Rate Effect | -29 | -29 | N/A | -121 | -117 |
| Beginning Cash Position | 137,468 | 137,468 | 137,468 | 191,792 | 191,792 |
| End Cash Position | 46,881 | 66,182 | 114,947 | 137,468 | 98,087 |
| Net Cash Flow | $-90,587 | $-71,286 | $-22,521 | $-54,324 | $-93,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,953 | -39,915 | -15,601 | -72,145 | -55,276 |
| Capital Expenditure | -3,594 | -2,527 | -1,097 | -4,949 | -3,684 |
| Free Cash Flow | -67,547 | -42,442 | -16,698 | -77,094 | -58,960 |